Cleveland Clinic Nephrology Update 2026 (Videos)

Comprehensive Updates in Chronic Kidney Disease, Glomerular Diseases, ADPKD, Resistant Hypertension, Cardio-Renal Syndrome, Onco-Nephrology, Vasculitis, and Precision Nephrology

Stay at the forefront of modern kidney medicine with Cleveland Clinic Nephrology Update 2026, a comprehensive continuing medical education (CME) program designed to deliver the latest evidence-based advances in nephrology. Developed by internationally recognized experts from the Cleveland Clinic, this educational conference provides clinicians with practical guidance on diagnosing, managing, and treating a broad spectrum of kidney diseases using the most current scientific evidence and emerging therapeutic innovations.

This advanced educational program explores contemporary developments in chronic kidney disease (CKD), glomerular diseases, resistant hypertension, cardio-kidney-metabolic syndrome, cystic kidney diseases, vasculitis, onco-nephrology, and critical care nephrology. Through expert-led lectures, evidence-based reviews, multidisciplinary discussions, and clinically relevant case presentations, participants gain practical strategies that can immediately improve patient outcomes across both inpatient and outpatient nephrology practice.

Designed for specialists managing complex renal disorders, this course emphasizes personalized treatment strategies, novel pharmacologic therapies, precision medicine, and multidisciplinary collaboration in the care of patients with acute and chronic kidney disease.

Product Details

• Course: Cleveland Clinic Nephrology Update 2026
• Provider: Cleveland Clinic
• Format: Videos
• Language: English
• Educational Level: Advanced
• Learning Format: Expert Lectures, Clinical Case Reviews, Evidence-Based Updates, Multidisciplinary Discussions

Course Overview

Kidney disease continues to evolve as one of the most complex areas of internal medicine, requiring physicians to remain current with rapidly expanding knowledge regarding disease mechanisms, novel therapeutics, precision diagnostics, and multidisciplinary management. Recent breakthroughs in nephrology—including advances in SGLT2 inhibitors, endothelin receptor antagonists, APOL1-targeted therapies, renal denervation, and cardio-kidney-metabolic medicine—are fundamentally changing patient care.

Cleveland Clinic Nephrology Update 2026 provides a comprehensive review of these developments while translating cutting-edge research into practical clinical management. Faculty review updated diagnostic strategies, evidence-based treatment recommendations, and innovative therapies for chronic kidney disease, glomerular disorders, hypertension, inherited kidney diseases, cancer-associated renal complications, and systemic disorders affecting renal function.

The curriculum emphasizes individualized patient care, multidisciplinary collaboration, prevention of disease progression, and optimization of long-term renal and cardiovascular outcomes.

What You’ll Learn

After completing this course, participants will be able to:

• Apply the latest advances in managing autosomal dominant polycystic kidney disease (ADPKD) and other cystic kidney disorders.
• Diagnose and treat major glomerular diseases using current evidence-based recommendations.
• Implement modern therapies for resistant hypertension, including renal denervation and emerging pharmacologic agents.
• Optimize management of cardio-renal and hepato-renal syndromes.
• Recognize and manage kidney complications associated with cancer therapies.
• Integrate precision medicine into chronic kidney disease management.
• Apply updated treatment strategies for immune-mediated renal diseases.
• Improve multidisciplinary care for patients with complex nephrological disorders.

Comprehensive Topics Covered

Chronic Kidney Disease (CKD)

Strengthen evidence-based management of chronic kidney disease.

Topics include:

• Chronic kidney disease
• CKD progression
• Renal function assessment
• Albuminuria
• Kidney protection
• Evidence-based management
• Precision nephrology

Faculty discuss contemporary strategies for slowing disease progression and reducing cardiovascular risk.

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Review modern management of inherited cystic kidney disorders.

Topics include:

• Autosomal dominant polycystic kidney disease (ADPKD)
• Cystic kidney disease
• Genetic kidney disorders
• Disease progression
• Tolvaptan therapy
• Imaging surveillance
• Long-term management

Participants learn practical approaches for individualized care of patients with inherited renal disease.

Glomerular Diseases

Master diagnosis and treatment of immune-mediated kidney disorders.

Topics include:

• IgA nephropathy
• Lupus nephritis
• Anti-GBM disease
• ANCA-associated glomerulonephritis
• Membranous nephropathy
• Minimal change disease
• Focal segmental glomerulosclerosis (FSGS)

Faculty review current immunosuppressive strategies, targeted therapies, and evolving clinical guidelines.

Vasculitis & Immune-Mediated Kidney Disease

Improve management of systemic inflammatory renal disorders.

Topics include:

• ANCA-associated vasculitis
• Small vessel vasculitis
• Anti-GBM disease
• Immune-mediated nephritis
• Autoimmune kidney disease
• Immunotherapy
• Long-term monitoring

Resistant Hypertension

Review emerging therapies for difficult-to-control blood pressure.

Topics include:

• Resistant hypertension
• Renal denervation
• Aldosterone synthase inhibitors
• Endothelin receptor antagonists
• Hepatic angiotensinogen silencing RNA
• Blood pressure optimization
• Cardiovascular risk reduction

Participants examine the latest evidence supporting novel antihypertensive therapies and interventional approaches.

Cardio-Kidney-Metabolic Syndrome

Explore the growing field of integrated cardiovascular and renal medicine.

Topics include:

• Cardio-kidney-metabolic syndrome
• Cardiorenal syndrome
• Diabetes and kidney disease
• SGLT2 inhibitors
• Heart failure
• Metabolic disease
• Integrated care

Hepato-Renal Syndrome

Update clinical management using contemporary evidence.

Topics include:

• Hepato-renal syndrome
• Cirrhosis
• Acute kidney injury
• Liver transplantation
• Vasoconstrictor therapy
• Volume management
• Critical care nephrology

Onco-Nephrology

Recognize renal complications associated with cancer therapy.

Topics include:

• Onco-nephrology
• Immune checkpoint inhibitors
• Targeted cancer therapies
• Chemotherapy nephrotoxicity
• Acute kidney injury
• Electrolyte disorders
• Cancer-related kidney disease

Faculty review prevention, diagnosis, and management of nephrotoxic complications in oncology patients.

Thrombotic Microangiopathy & Rare Kidney Diseases

Expand expertise in uncommon renal disorders.

Topics include:

• Thrombotic microangiopathy (TMA)
• APOL1 nephropathy
• Complement-mediated disease
• Rare glomerular disorders
• Precision diagnostics
• Biomarkers
• Personalized treatment

Emerging Therapies in Nephrology

Stay current with innovations transforming renal medicine.

Topics include:

• Precision nephrology
• Novel biologic therapies
• RNA-based therapeutics
• Targeted therapies
• Clinical trials
• Future treatment strategies
• Translational nephrology

Learning Objectives

Upon completion of this educational activity, participants will be able to:

• Describe advances in the management of ADPKD and other cystic kidney diseases.
• Apply updated evidence-based treatment strategies for glomerular diseases, including IgA nephropathy, lupus nephritis, anti-GBM disease, ANCA-associated glomerulonephritis, thrombotic microangiopathy, and APOL1 nephropathy.
• Evaluate contemporary therapies for resistant hypertension, including renal denervation, aldosterone synthase inhibitors, endothelin receptor antagonists, and hepatic angiotensinogen silencing RNA.
• Integrate the latest evidence into the management of cardio-renal and hepato-renal syndromes.
• Recognize nephrotoxic effects of immune checkpoint inhibitors and targeted cancer therapies while optimizing kidney care in oncology patients.

Educational Highlights

• Chronic Kidney Disease (CKD)
• Nephrology
• Glomerular Diseases
• IgA Nephropathy
• Lupus Nephritis
• ANCA Vasculitis
• Anti-GBM Disease
• APOL1 Nephropathy
• Autosomal Dominant Polycystic Kidney Disease (ADPKD)
• Resistant Hypertension
• Renal Denervation
• Cardio-Kidney-Metabolic Syndrome
• Cardiorenal Syndrome
• Hepato-Renal Syndrome
• Onco-Nephrology
• Immune Checkpoint Inhibitors
• Thrombotic Microangiopathy (TMA)
• Precision Nephrology
• Kidney Disease Therapeutics
• Continuing Medical Education (CME)

Why This Course Stands Out

Cleveland Clinic Nephrology Update 2026 provides an exceptional review of the rapidly evolving field of kidney medicine by combining cutting-edge scientific discoveries with practical clinical guidance. Unlike traditional nephrology conferences focused solely on chronic kidney disease, this program integrates glomerular disorders, hypertension, cardio-renal medicine, inherited kidney diseases, oncology-related nephrology, and emerging precision therapies into one comprehensive educational experience. The course equips clinicians with immediately applicable strategies for managing some of the most challenging renal diseases encountered in modern practice.

Target Audience

This educational activity is ideal for:

• Nephrologists
• Cardiologists
• Critical Care Physicians
• Intensivists
• Medical Oncologists
• Palliative Medicine Specialists
• Internal Medicine Physicians
• Hospitalists
• Transplant Nephrologists
• Hypertension Specialists
• Rheumatologists
• Oncology Nurse Practitioners
• Nephrology Fellows
• Internal Medicine Residents
• Physician Assistants
• Advanced Practice Providers involved in kidney disease management

Why Choose This Course?

Whether you specialize in nephrology, cardiology, intensive care, oncology, transplant medicine, or internal medicine, Cleveland Clinic Nephrology Update 2026 provides one of the most comprehensive educational reviews available on modern kidney disease management. Through expert-led lectures, evidence-based recommendations, multidisciplinary discussions, and practical clinical insights, participants gain the knowledge needed to integrate novel therapies, optimize diagnostic evaluation, improve cardiovascular and renal outcomes, and deliver precision care for patients with complex kidney disorders.

Topics